STOCK TITAN

Michael Henderson plans $3.84M APGE stock sale in Form 144 (APGE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Michael Henderson filed a Form 144 indicating an intent to sell 60,000 shares of APGE common stock. The planned sale is through The Charles Schwab Corporation and is tied to an aggregate market value of $3,840,000, with an approximate sale date of February 11, 2026 on the Nasdaq.

The notice states these shares were acquired via RSU vesting between June 2, 2023 and December 14, 2023, with 60,000 securities acquired on June 2, 2023. The filing notes that 54,833,587 shares of the issuer’s common stock were outstanding. Over the prior three months, Henderson reported selling 40,000, 20,000 and 20,000 APGE common shares for gross proceeds of $3,000,312, $1,507,650 and $1,622,186, respectively.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the latest Form 144 filing reveal about APGE?

The Form 144 shows a planned insider sale of APGE shares. Shareholder Michael Henderson filed to potentially sell 60,000 common shares, valued at $3,840,000, with an approximate sale date of February 11, 2026, through The Charles Schwab Corporation on Nasdaq.

How many APGE shares does Michael Henderson plan to sell under Form 144?

Michael Henderson plans to sell up to 60,000 APGE common shares. The filing lists these shares with an aggregate market value of $3,840,000 and identifies The Charles Schwab Corporation as broker, with trading expected around February 11, 2026, on the Nasdaq exchange.

How were the APGE shares in Michael Henderson’s Form 144 acquired?

The APGE shares were acquired through RSU vesting. The filing states the 60,000 common shares came from RSU vesting occurring between June 2, 2023 and December 14, 2023, with the acquisition date and payment date both recorded as June 2, 2023.

How many APGE shares are outstanding according to this Form 144?

The Form 144 reports 54,833,587 APGE common shares outstanding. This figure provides context for the planned 60,000-share sale, showing the size of the potential disposition relative to the issuer’s total outstanding common stock at the time of the notice.

What APGE stock sales has Michael Henderson made in the last three months?

The filing lists three APGE stock sales over three months. Henderson sold 40,000 shares on December 4, 2025, 20,000 shares on December 10, 2025, and 20,000 shares on January 14, 2026, for gross proceeds of $3,000,312, $1,507,650 and $1,622,186 respectively.

Which broker and exchange are involved in the APGE Form 144 sale?

The planned APGE sale uses The Charles Schwab Corporation and Nasdaq. The Form 144 identifies The Charles Schwab Corporation in Westlake, Texas as broker, with the common stock listed for sale on the Nasdaq stock market around February 11, 2026.
Apogee Therapeutics Inc

NASDAQ:APGE

APGE Rankings

APGE Latest News

APGE Latest SEC Filings

APGE Stock Data

4.71B
50.12M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
WALTHAM